ICYMI: America’s biopharmaceutical companies are taking on COVID-19
By Andrew Powaleny | March 16, 2020
The biopharmaceutical industry is taking on COVID-19, a disease caused by a novel strain of coronavirus, through research and development (R&D) into prevention and treatment, in-kind financial...
Read More
ICYMI: Continued biopharmaceutical action on COVID-19
By Andrew Powaleny | March 6, 2020
Updated 3/11/2020 This week, PhRMA and senior executives and researchers from four member companies met with key policy makers on Capitol Hill to discuss the industry’s response to COVID-19, a...
Read More
Working together to combat coronavirus
By Richard Moscicki, M.D. | February 6, 2020
The World Health Organization (WHO) recently declared the outbreak of 2019-nCoV, a novel strain of coronavirus that originated in Wuhan, China, a global health emergency. In the last three weeks,...
Read More
Guest post: Help celebrate #ChampionsofScience: Nominate a pioneering researcher for the 2018 Dr. Paul Janssen Award for Biomedical Research
By Guest Contributor | January 29, 2018
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...
Read More
The journey to better health care requires a holistic view
By Guest Contributor | September 18, 2017
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...
Read More
Helping those affected by the 2017 hurricane season
By Holly Campbell | August 31, 2017
This post has been updated as of 10/30/2017 to reflect relief efforts for Hurricanes Harvey, Irma and Maria. Given the unprecedented scale of the devastation and flooding caused by Hurricanes...
Read More
Celebrating PRIDE in biopharmaceutical science
By Andrew Powaleny | June 1, 2017
Today marks the beginning of Lesbian, Gay, Bisexual, and Transgender (LGBT) Pride Month and we are proud to join with our member companies in celebrating our support for the LGBT community. We...
Read More
Guest Post: The importance of a modern FDA in drug discovery
By Guest Contributor | March 22, 2017
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...
Read More
Exploring the new era of medicine
By Bill Chin, M.D. | February 21, 2017
We are in a new era of medicine where innovations are transforming our ability to attack the cause of disease, not just the symptoms. Where treatment decisions are increasingly focused on the...
Read More
Guest Post: Johnson and Johnson is celebrating outstanding scientists: Who will be next?
By Guest Contributor | February 15, 2017
As a health care company with the mission of bringing forward transformational solutions for patients and consumers, innovative scientific advances are the essence of our success. We believe that...
Read More
Medicare Monday (100)
340B Spotlight (43)
Cost & Consequence (0)
